Citius Pharmaceuticals, Inc. Revenue 2011–2022
Citius Pharmaceuticals, Inc. annual/quarterly revenue history and growth rate from 2011 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Citius Pharmaceuticals, Inc. revenue for the quarter ending March 31, 2026 was 1.7 M.
- Citius Pharmaceuticals, Inc. revenue for the twelve months ending March 31, 2026 was 5.6 M.
- Citius Pharmaceuticals, Inc. annual revenue for 2022 was 90000, a 0.00% increase from 2021.
- Citius Pharmaceuticals, Inc. annual revenue for 2021 was 90000, a 0.00% increase from 2020.
- Citius Pharmaceuticals, Inc. annual revenue for 2020 was 90000, a 0.00% increase from 2019.
- Citius Pharmaceuticals, Inc. annual revenue for 2019 was 90000.
Citius Pharmaceuticals, Inc. (CTXR) — Frequently Asked Questions
Citius Pharmaceuticals, Inc. (CTXR) is a publicly traded US company. It has a market capitalization of $84M. In fiscal 2022 it reported revenue of $90,000 and net income of -$34M. Explore CTXR's stock price, financial statements, earnings history, margins and key ratios below.
What is Citius Pharmaceuticals, Inc.'s market cap?
Citius Pharmaceuticals, Inc. (CTXR) has a market capitalization of $84M.
What is the CTXR stock price?
CTXR trades at $0.57 (+3.54% on the day).
How much revenue does Citius Pharmaceuticals, Inc. make?
Citius Pharmaceuticals, Inc. reported revenue of $90,000 in fiscal 2022.
Is CTXR profitable?
In fiscal 2022, Citius Pharmaceuticals, Inc. reported net income of -$34M.